BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 18175054)

  • 1. Patterns in the prevalence of hepatitis C virus infection at the start of hemodialysis in Japan.
    Iwasa Y; Otsubo S; Sugi O; Sato K; Asamiya Y; Eguchi A; Iwasaki T; Matsuda N; Kikuchi K; Ikebe N; Miwa N; Kimata N; Uchida K; Uchida S; Nitta K; Akiba T
    Clin Exp Nephrol; 2008 Feb; 12(1):53-7. PubMed ID: 18175054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of hepatitis C virus infection among hemodialysis patients in a single center in Yemen.
    Selm SB
    Saudi J Kidney Dis Transpl; 2010 Nov; 21(6):1165-8. PubMed ID: 21060200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low prevalence of anti-hepatitis C virus antibodies in female hemodialysis patients without blood transfusion: a multicenter analysis.
    Nakayama E; Liu JH; Akiba T; Marumo F; Sato C
    J Med Virol; 1996 Mar; 48(3):284-8. PubMed ID: 8801291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-ENA antibody profile in hepatitis C patients undergoing hemodialysis.
    Batchoun RG; Al-Najdawi MA; Al-Taamary S
    Saudi J Kidney Dis Transpl; 2011 Jul; 22(4):682-8. PubMed ID: 21743211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hepatitis C: epidemiology and therapy--with special reference to long-term prognosis after IFN therapy].
    Fujiyama S; Tanaka M
    Rinsho Byori; 2000 Jan; 48(1):5-13. PubMed ID: 10756668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Infection of hepatitis C virus in patients with chronic renal failure undergoing hemodialysis therapy and staff members].
    Miyasaka M
    Nihon Jinzo Gakkai Shi; 1991 Oct; 33(10):989-99. PubMed ID: 1722830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Standardized prevalence ratios for chronic hepatitis C virus infection among adult Japanese hemodialysis patients.
    Ohsawa M; Kato K; Itai K; Tanno K; Fujishima Y; Konda R; Okayama A; Abe K; Suzuki K; Nakamura M; Onoda T; Kawamura K; Sakata K; Akiba T; Fujioka T
    J Epidemiol; 2010; 20(1):30-9. PubMed ID: 19881229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The Veneto Region's Registry of Dialysis and Transplantation: 2006-2007 report].
    Antonucci F; Camerin E; Feriani M; Nordio M; Piccoli A; Rossi B; Tessitore N
    G Ital Nefrol; 2009; 26 Suppl 48():S5-56. PubMed ID: 19927265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of hepatitis C virus antibody in patients on chronic hemodialysis.
    Nomiyama K; Tsuji H; Ikeda K; Kawatoko T; Kashiwagi S; Nakamura S; Fujishima M
    Fukuoka Igaku Zasshi; 1998 Aug; 89(8):232-7. PubMed ID: 9778915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of occult hepatitis C infection in chronic hemodialysis and kidney transplant patients.
    Baid-Agrawal S; Schindler R; Reinke P; Staedtler A; Rimpler S; Malik B; Frei U; Berg T
    J Hepatol; 2014 May; 60(5):928-33. PubMed ID: 24447875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis C viral infection in a Chinese hemodialysis unit.
    Li H; Wang SX
    Chin Med J (Engl); 2010 Dec; 123(24):3574-7. PubMed ID: 22166633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of occult hepatitis B and hepatitis C virus infections in Turkish hemodialysis patients.
    Yakaryilmaz F; Gurbuz OA; Guliter S; Mert A; Songur Y; Karakan T; Keles H
    Ren Fail; 2006; 28(8):729-35. PubMed ID: 17162434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis B and C and renal failure.
    Zacks SL; Fried MW
    Infect Dis Clin North Am; 2001 Sep; 15(3):877-99. PubMed ID: 11570146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology and clinical significance of chronic hepatitis-related viruses infection in hemodialysis patients from Taiwan.
    Dai CY; Yu ML; Chuang WL; Sung MH; Lin ZY; Chen SC; Hsieh MY; Wang LY; Tsai JF; Chang WY
    Nephron; 2002 Feb; 90(2):148-53. PubMed ID: 11818698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of hepatitis E virus infection in regular hemodialysis patients.
    Kikuchi K; Yoshida T; Kimata N; Sato C; Akiba T
    Ther Apher Dial; 2006 Apr; 10(2):193-7. PubMed ID: 16684223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of anti-hepatitis C virus antibody and chronic liver disease among atomic bomb survivors.
    Fujiwara S; Kusumi S; Cologne J; Akahoshi M; Kodama K; Yoshizawa H
    Radiat Res; 2000 Jul; 154(1):12-9. PubMed ID: 10856960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis C antibodies in patients on peritoneal dialysis: prevalence and risk factors.
    Lee GS; Roy DK; Fan FY; Thanaletchumi K; Woo KT
    Perit Dial Int; 1996; 16 Suppl 1():S424-8. PubMed ID: 8728237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of hepatitis C virus in patients with terminal renal disease undergoing dialysis in southern Brazil: prevalence, risk factors, genotypes, and viral load dynamics in hemodialysis patients.
    Vidales-Braz BM; da Silva NM; Lobato R; Germano FN; da Mota LD; Barros EJ; de Martinez AM
    Virol J; 2015 Feb; 12():8. PubMed ID: 25644891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seroepidemiology of hepatitis C virus infection in hemodialysis patients and the general population in Fukuoka and Okinawa, Japan.
    Hayashi J; Yoshimura E; Nabeshima A; Kishihara Y; Ikematsu H; Hirata M; Maeda Y; Kashiwagi S
    J Gastroenterol; 1994 Jun; 29(3):276-81. PubMed ID: 7520320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis C virus infection during haemodialysis in India.
    Agarwal SK; Dash SC; Irshad M
    J Assoc Physicians India; 1999 Dec; 47(12):1139-43. PubMed ID: 11225211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.